Topic: breast cancer

Roche

2. Roche

Roche has been bracing itself for U.S. biosimilars to its three best-selling drugs by introducing new drugs such as multiple sclerosis antibody drug Ocrevus, hemophilia therapy Hemlibra, HER2 antibody-drug conjugate Kadcyla, and PD-L1 Tecentriq, among others. But they all face competition.